Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0652
+0.0117 (21.87%)
At close: Jul 27, 2026
Hepion Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2.98 | -8.28 | -13.19 | -48.93 | -42.2 | -32.72 |
Depreciation & Amortization | - | - | 0.03 | 0.07 | 0.08 | 0.09 |
Other Amortization | - | - | 1.27 | - | - | - |
Asset Writedown & Restructuring Costs | 0.4 | 0.4 | - | 3.19 | 1.87 | - |
Stock-Based Compensation | - | 0.02 | 0.79 | 1.34 | 2.55 | 4.67 |
Other Operating Activities | -0.7 | 4.09 | -4.43 | 0.47 | -0.41 | 2.31 |
Change in Accounts Payable | 0.08 | 0 | -4.55 | 0.3 | 2.25 | -1.07 |
Change in Other Net Operating Assets | 1.63 | 0.49 | 1.86 | 2.67 | 0.91 | -4.5 |
Operating Cash Flow | -1.58 | -3.27 | -18.22 | -40.89 | -34.96 | -31.22 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | -0.01 | -0.02 | -0.13 |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | - |
Sale (Purchase) of Intangibles | -0.13 | -0.13 | - | - | - | - |
Other Investing Activities | - | - | -0.6 | - | - | - |
Investing Cash Flow | -0.13 | -0.13 | -0.6 | -0.01 | -0.01 | -0.13 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Repaid | - | -3.37 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | - | - | -0.18 |
Total Debt Repaid | -0.53 | -3.37 | - | - | - | -0.18 |
Net Debt Issued (Repaid) | -0.53 | -3.37 | - | - | - | -0.18 |
Issuance of Common Stock | 0.25 | 9 | 4.35 | 4.49 | - | 82.15 |
Other Financing Activities | - | -0.8 | - | - | -2 | - |
Financing Cash Flow | -0.28 | 4.83 | 4.35 | 4.49 | -5.14 | 81.98 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | 0.09 | 0.01 | -0.05 | - |
Net Cash Flow | -1.98 | 1.42 | -14.38 | -36.4 | -40.16 | 50.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.58 | -3.27 | -18.22 | -40.9 | -34.98 | -31.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.14 | -0.35 | -148.23 | -515.05 | -458.85 | -446.07 |
Levered Free Cash Flow | -0.23 | -2.51 | -14.22 | -25.88 | -23.97 | -15.02 |
Unlevered Free Cash Flow | -0.23 | -2.5 | -14.7 | -25.87 | -23.96 | -15.02 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.02 | 0.02 | - | - | 0 | 0 |
Change in Working Capital | 1.71 | 0.49 | -2.68 | 2.97 | 3.15 | -5.57 |